Fungal Diagnostics for a Healthier Tomorrow
IMMY is a US-based organization with a dedicated focus in mycology. We develop, manufacture, and distribute innovative diagnostic tests and reagents for fungal diseases. Above all, IMMY’s mission is to improve health and save lives for patients all over the world.
Billions at Risk of Serious Illness
The global burden of fungal infections continues to grow throughout the world. From community-acquired to hospital-associated to advanced HIV diseases, fungal infections affect more than 1 billion people globally, accounting for 1.5 million deaths every year. (gaffi.org)
These infections need greater awareness among governments, health agencies, and communities, but more importantly, they need to become better understood and recognizable among those physicians who are providing care to these patients.
Comprehensive Fungal Diagnostics Tailored to Every Provider
Accurate diagnosis is key to proper patient care, especially with the continuing rise of improper or unnecessary treatment which can lead to antimicrobial resistance. Providing healthcare professionals rapid, accurate, and affordable diagnostics is lifesaving for many patients.
- Lateral Flow Assays
Single Test Format with Rapid Results
Simple workflows require minimal training or little hands-on time.
Cryptococcal Antigen LFA
Results in 10 minutes. Highly sensitive & specific. 5 easy steps.
Aspergillus Galactomannan LFA
Results in 45 minutes. Highly sensitive & specific. Test more often.
Coccidioides Antibody LFA
Results in 30 minutes. Reduce send-out testing. Run on all shifts.
- Enzyme Immunoassays
Scalable Solutions for Any Lab
Ideal for both high-volume reference labs and smaller hospital settings.
Histoplasma Galactomannan EIA
Results in 2 Hours and 15 Minutes, Reduce send-out testing. 96 Patients per Plate.
Coccidioides Antibody EIA
Results in 2 Hours. Highly sensitive and specific. Two 96-well plates. Offers IgG and IgM differentiation.
Blastomyces Antibody EIA
Results in 2 Hours. Highly sensitive and specific. Only commercially available diagnostic ELISA kit for the detection of Blastomyces antibody.
Cryptococcal Antigen EIA
Results in 2 hours. Most sensitive and specific EIA for the detection of cryptococcal antigen.
- Polymerase Chain Reaction
Next-Generation Diagnostics
Detects fungal pathogens with precision at the molecular level. ‘Ready to use’ reagents – no resuspension/dilution steps required. Compatible with existing laboratory equipment. Enables quick laboratory reporting to support clinical decision-making when time is of the essence.
Candida auris PCR
Sensitive to <10 Candida auris genome copies. Proven efficacy in clinical decision making for infection control and patient management.
Candida species PCR
Detection of the six main causative species associated with invasive candidiasis (IC): C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. dubliniensis, C. krusei.
Aspergillus PCR
Differentiation of A. terreus and Aspergillus species. Proven efficacy in the diagnosis of Invasive Aspergillosis (IA).
Pneumocystis jirovecii PCR
Human β-globin gene (Endogenous Internal Control). Proven efficacy in the diagnosis of Pneumocystis Pneumonia (PCP).
- Other Products
Proven Technologies, Trusted Results
Time-honored methods for precise detection.
Latex Agglutination
These antibody or antigen detection systems are semi-quantitative tests that detect agglutinating antibodies in the serum of patients with the respective fungal diseases. The LA tests can aid in the diagnosis of the disease.
Cleargel™ Immunodiffusion
In order to overcome the inherently opaque appearance of agarose immunodiffusion plates, IMMY developed Cleargel™. Cleargel™ is a proprietary gelling agent which produces an ultra-clear gel structure for easy visualization of precipitin bands.
Complement Fixation
Fungal antigens and positive controls are used to detect antibodies in patient serum by the complement fixation (CF) procedure.
MycoDDR
MycoDDR is a reliable processing system that facilitates the digestion and decontamination of patient specimens in a controlled process, which is essential for mycobacterium survival and recovery.
Single Test Format with Rapid Results
Simple workflows require minimal training or little hands-on time.

Cryptococcal Antigen LFA
Results in 10 minutes. Highly sensitive & specific. 5 easy steps.

Aspergillus Galactomannan LFA
Results in 45 minutes. Highly sensitive & specific. Test more often.

Coccidioides Antibody LFA
Results in 30 minutes. Reduce send-out testing. Run on all shifts.
Scalable Solutions for Any Lab
Ideal for both high-volume reference labs and smaller hospital settings.

Histoplasma Galactomannan EIA
Results in 2 Hours and 15 Minutes, Reduce send-out testing. 96 Patients per Plate.

Coccidioides Antibody EIA
Results in 2 Hours. Highly sensitive and specific. Two 96-well plates. Offers IgG and IgM differentiation.

Blastomyces Antibody EIA
Results in 2 Hours. Highly sensitive and specific. Only commercially available diagnostic ELISA kit for the detection of Blastomyces antibody.

Cryptococcal Antigen EIA
Results in 2 hours. Most sensitive and specific EIA for the detection of cryptococcal antigen.
Next-Generation Diagnostics
Detects fungal pathogens with precision at the molecular level. ‘Ready to use’ reagents – no resuspension/dilution steps required. Compatible with existing laboratory equipment. Enables quick laboratory reporting to support clinical decision-making when time is of the essence.

Candida auris PCR
Sensitive to <10 Candida auris genome copies. Proven efficacy in clinical decision making for infection control and patient management.

Candida species PCR
Detection of the six main causative species associated with invasive candidiasis (IC): C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. dubliniensis, C. krusei.

Aspergillus PCR
Differentiation of A. terreus and Aspergillus species. Proven efficacy in the diagnosis of Invasive Aspergillosis (IA).

Pneumocystis jirovecii PCR
Human β-globin gene (Endogenous Internal Control). Proven efficacy in the diagnosis of Pneumocystis Pneumonia (PCP).
Proven Technologies, Trusted Results
Time-honored methods for precise detection.

Latex Agglutination
These antibody or antigen detection systems are semi-quantitative tests that detect agglutinating antibodies in the serum of patients with the respective fungal diseases. The LA tests can aid in the diagnosis of the disease.

Cleargel™ Immunodiffusion
In order to overcome the inherently opaque appearance of agarose immunodiffusion plates, IMMY developed Cleargel™. Cleargel™ is a proprietary gelling agent which produces an ultra-clear gel structure for easy visualization of precipitin bands.

Complement Fixation
Fungal antigens and positive controls are used to detect antibodies in patient serum by the complement fixation (CF) procedure.

MycoDDR
MycoDDR is a reliable processing system that facilitates the digestion and decontamination of patient specimens in a controlled process, which is essential for mycobacterium survival and recovery.
“ IMMY's tests, including tests for histoplasmosis, cryptococcosis, and coccidioidomycosis, have enabled early and rapid diagnosis. This has provided patients with timely treatment, directly impacting on their survival. ”
“ The rapid techniques implemented in the laboratory allowed to increase diagnostic sensitivity and reduce the response time in mycological diagnosis, which allowed for the implementation of early targeted treatment. ”
“ At my work institution I have had the opportunity to work with IMMY's products, specifically CrAg LFA, Aspergillus GM LFA, and serology for Histoplasma. All of them have been a very useful tool for a timely diagnosis. In the case of the CrAg LFA, it has been a valuable tool for early detection of Cryptococcosis in HIV patients, increasing survival.
Fungal serology has been very useful for the detection of Histoplasma spp and Paracoccidioides spp, since we are a country endemic for these mycoses.
Without a doubt, IMMY products have been a great ally in my work. ”
5 million
lives impacted every year by IMMY diagnostics
45 years
of excellence
100+
employees dedicated to 1 mission
100%
committed to proving the world’s best fungal diagnostics
Bringing Fungal Diagnostics to a Global Audience
We are continually working to bring diagnostics closer to the patient. Currently, IMMY’s products are available in over 80 countries.
Fungal Disease Education
Explore the epidemiology and global impact of often-overlooked fungal diseases.

Cryptococcosis
Cryptococcal meningitis is one of the most common opportunistic infections among HIV/AIDS patients, estimating more than 220,000 cases and 181,000 deaths worldwide each year.

Histoplasmosis
Histoplasmosis is the most prevalent endemic mycosis in the United States. Histoplasma capsulatum is a dimorphic fungus found in areas of endemicity around the world, notably in river basins.

Candida Auris Infections
Over the past decade, Candida auris has emerged as a worldwide public health threat. Since its first isolation in 2009 in Japan, C. auris infections have been reported in over 30 countries.
Stay Informed on Mycology Research & Global Health Standards
Access expert resources, industry news, and the latest updates on fungal diseases, diagnostics, and world health guidelines.

WHO Fungal Priority Pathogens List
The World Health Organization publishes its first ever list of fungal priority pathogens to guide research, development and public health action.

Detection and Treatment of Endemic Mycoses
Authors summarize relevant information about epidemiological, clinical, diagnostic, and treatment aspects of the most common endemic mycoses, including blastomycosis, coccidioidomycosis, histoplasmosis, and more.

Fungal infections in immunocompromised critically ill patients
In-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.
Get in Touch
Inquire for products, connect with IMMY experts in your region, or submit a request for collaboration.